Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Peptic Ulcer

  Free Subscription


Articles published in Eur J Gastroenterol Hepatol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    January 2020
  1. ZULLO A
    The current role of dual therapy for treatment of Helicobacter pylori: back to the future?
    Eur J Gastroenterol Hepatol. 2020 Jan 8. doi: 10.1097/MEG.0000000000001654.
    PubMed     Text format    


    December 2019
  2. ZHANG Y, Zhu YJ, Zhao Z, Zhao JT, et al
    Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.
    Eur J Gastroenterol Hepatol. 2019 Dec 16. doi: 10.1097/MEG.0000000000001646.
    PubMed     Text format     Abstract available


    November 2019
  3. CHEN C, Zhang C, Wang X, Zhang F, et al
    Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.
    Eur J Gastroenterol Hepatol. 2019 Nov 7. doi: 10.1097/MEG.0000000000001601.
    PubMed     Text format     Abstract available


    October 2019
  4. DURICEK M, Banovcin P Jr, Halickova T, Hyrdel R, et al
    Comprehensive analysis of acidic pharyngeal reflux before and after proton pump inhibitor treatment in patients with suspected laryngopharyngeal reflux.
    Eur J Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1097/MEG.0000000000001584.
    PubMed     Text format     Abstract available


    September 2019
  5. LI Y, Li H, Zhu Q, Tsochatzis E, et al
    Effect of acute upper gastrointestinal bleeding manifestations at admission on the in-hospital outcomes of liver cirrhosis: hematemesis versus melena without hematemesis.
    Eur J Gastroenterol Hepatol. 2019 Sep 11. doi: 10.1097/MEG.0000000000001524.
    PubMed     Text format     Abstract available


    August 2019
  6. JANKA T, Tornai T, Borbely B, Tornai D, et al
    Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
    Eur J Gastroenterol Hepatol. 2019 Aug 27. doi: 10.1097/MEG.0000000000001499.
    PubMed     Text format     Abstract available


  7. KAPIZIONI C, Koutoufaris G, Ntouli V, Makris K, et al
    Optimal duration of concomitant nonbismuth quadruple therapy as first-line therapy for Helicobacter pylori: a prospective, open-label, comparative study.
    Eur J Gastroenterol Hepatol. 2019 Aug 20. doi: 10.1097/MEG.0000000000001517.
    PubMed     Text format     Abstract available


  8. KAWADA T
    Sex difference in patients with Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2019;31:1070.
    PubMed     Text format    


    April 2019
  9. JUNG DH, Ko BS, Kim YJ, Kim WY, et al
    Comparison of risk scores and shock index in hemodynamically stable patients presenting to the emergency department with nonvariceal upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2019 Apr 18. doi: 10.1097/MEG.0000000000001422.
    PubMed     Text format     Abstract available


  10. NING L, Liu R, Lou X, Du H, et al
    Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: a systemic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2019 Apr 3. doi: 10.1097/MEG.0000000000001398.
    PubMed     Text format     Abstract available


    March 2019
  11. FERRO A, Morais S, Pelucchi C, Dierssen-Sotos T, et al
    Sex differences in the prevalence of Helicobacter pylori infection: an individual participant data pooled analysis (StoP Project).
    Eur J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1097/MEG.0000000000001389.
    PubMed     Text format     Abstract available


    February 2019
  12. LAI SW, Lin CL, Liao KF
    Proton pump inhibitors therapy and the risk of major osteoporotic nonhip fractures in older adults in Taiwan.
    Eur J Gastroenterol Hepatol. 2019;31:272-273.
    PubMed     Text format    


    November 2018
  13. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Response to letter: 'Proton pump inhibitors therapy and the risk of major osteoporotic nonhip fractures in older adults in Taiwan'.
    Eur J Gastroenterol Hepatol. 2018 Nov 19. doi: 10.1097/MEG.0000000000001309.
    PubMed     Text format    


    September 2018
  14. WILKINSON J, Wade A, Thomas SJ, Jenner B, et al
    Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Eur J Gastroenterol Hepatol. 2018 Sep 27. doi: 10.1097/MEG.0000000000001258.
    PubMed     Text format     Abstract available


    July 2018
  15. ISLAM MM, Poly TN, Walther BA, Dubey NK, et al
    Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 19. doi: 10.1097/MEG.0000000000001198.
    PubMed     Text format     Abstract available


  16. JARUVONGVANICH V, Poonsombudlert K, Ungprasert P
    Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Jul 6. doi: 10.1097/MEG.0000000000001204.
    PubMed     Text format     Abstract available


    June 2018
  17. TALEBI BEZMIN ABADI A, Yamaoka Y
    Call for shift in Helicobacter pylori treatment.
    Eur J Gastroenterol Hepatol. 2018;30:687.
    PubMed     Text format    


    April 2018
  18. PONZETTO A, Figura N
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2018;30:490.
    PubMed     Text format    


    March 2018
  19. KHAN MY, Siddiqui WJ, Alvarez C, Aggarwal S, et al
    Reduction in postpercutaneous coronary intervention angina in addition to gastrointestinal events in patients on combined proton pump inhibitors and dual antiplatelet therapy: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2018 Mar 28. doi: 10.1097/MEG.0000000000001125.
    PubMed     Text format     Abstract available


  20. PELLICANO R, Durazzo M
    Helicobacter pylori among patients with uninvestigated dyspepsia: issues to be remembered.
    Eur J Gastroenterol Hepatol. 2018;30:278-279.
    PubMed     Text format    


    February 2018
  21. FIORINI G, Zullo A, Saracino IM, Gatta L, et al
    Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
    Eur J Gastroenterol Hepatol. 2018 Feb 23. doi: 10.1097/MEG.0000000000001102.
    PubMed     Text format     Abstract available


  22. XAVIER SA, Vilas-Boas R, Boal Carvalho P, Magalhaes JT, et al
    Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2018 Feb 12. doi: 10.1097/MEG.0000000000001087.
    PubMed     Text format     Abstract available


    November 2017
  23. SUKI M, Leibovici Weissman Y, Boltin D, Itskoviz D, et al
    Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study.
    Eur J Gastroenterol Hepatol. 2017 Nov 8. doi: 10.1097/MEG.0000000000001014.
    PubMed     Text format     Abstract available


  24. PELLICANO R
    Helicobacter pylori among patients with cirrhosis: incidence or prevalence?
    Eur J Gastroenterol Hepatol. 2017;29:1315.
    PubMed     Text format    


    September 2017
  25. BARAN M, Cagan Appak Y, Karakoyun M, Yalcinkaya S, et al
    The overlap of gastroesophageal reflux disease and functional constipation in children: the efficacy of constipation treatment.
    Eur J Gastroenterol Hepatol. 2017 Sep 13. doi: 10.1097/MEG.0000000000000979.
    PubMed     Text format     Abstract available


  26. COSTA S, Soares JB, Goncalves R
    Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
    Eur J Gastroenterol Hepatol. 2017 Sep 4. doi: 10.1097/MEG.0000000000000960.
    PubMed     Text format     Abstract available


    August 2017
  27. MALMI H, Kautiainen H, Virta LJ, Farkkila MA, et al
    Outcomes of patients hospitalized with peptic ulcer disease diagnosed in acute upper endoscopy.
    Eur J Gastroenterol Hepatol. 2017 Aug 29. doi: 10.1097/MEG.0000000000000951.
    PubMed     Text format     Abstract available


  28. SIECZKOWSKA A, Landowski P, Zagozdzon P, Kaminska B, et al
    The association of proton pump inhibitor therapy and small bowel bacterial overgrowth in children.
    Eur J Gastroenterol Hepatol. 2017 Aug 10. doi: 10.1097/MEG.0000000000000946.
    PubMed     Text format    


    July 2017
  29. ZHOU YJ, Zheng JN, Zhou YF, Han YJ, et al
    Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2017 Jul 25. doi: 10.1097/MEG.0000000000000943.
    PubMed     Text format     Abstract available


  30. POGORZELSKA J, Lapinska M, Kalinowska A, Lapinski TW, et al
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Jul 11. doi: 10.1097/MEG.0000000000000928.
    PubMed     Text format     Abstract available


  31. JENSEN BES, Hansen JM, Larsen KS, Junker AB, et al
    Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
    Eur J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1097/MEG.0000000000000934.
    PubMed     Text format     Abstract available


    June 2017
  32. VIAZIS N, Katopodi K, Karamanolis G, Denaxas K, et al
    Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
    Eur J Gastroenterol Hepatol. 2017 Jun 16. doi: 10.1097/MEG.0000000000000925.
    PubMed     Text format     Abstract available


    May 2017
  33. FILL MALFERTHEINER S, Seelbach-Gobel B, Costa SD, Ernst W, et al
    Impact of gastroesophageal reflux disease symptoms on the quality of life in pregnant women: a prospective study.
    Eur J Gastroenterol Hepatol. 2017 May 3. doi: 10.1097/MEG.0000000000000905.
    PubMed     Text format     Abstract available


  34. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017;29:552-559.
    PubMed     Text format     Abstract available


    April 2017
  35. PELLICANO R, Fagoonee S
    Any role for proton pump inhibitors in the relationship between new erosive oesophagitis and abdominal visceral fat?
    Eur J Gastroenterol Hepatol. 2017;29:489.
    PubMed     Text format    


  36. NAM SY, Kim YW, Park BJ, Ryu KH, et al
    Effect of abdominal visceral fat on the development of new erosive oesophagitis: a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2017;29:388-395.
    PubMed     Text format     Abstract available


    February 2017
  37. ROYSTON C, Bardhan KD
    Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Eur J Gastroenterol Hepatol. 2017 Feb 1. doi: 10.1097/MEG.0000000000000845.
    PubMed     Text format     Abstract available


    January 2017
  38. SMITH S, Boyle B, Brennan D, Buckley M, et al
    The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Eur J Gastroenterol Hepatol. 2017 Jan 10. doi: 10.1097/MEG.0000000000000822.
    PubMed     Text format     Abstract available


    December 2016
  39. CARES K, Al-Ansari N, Macha S, Zoubi N, et al
    Risk of small intestinal bacterial overgrowth with chronic use of proton pump inhibitors in children.
    Eur J Gastroenterol Hepatol. 2016 Dec 27. doi: 10.1097/MEG.0000000000000815.
    PubMed     Text format     Abstract available


    November 2016
  40. UPALA S, Sanguankeo A, Saleem SA, Jaruvongvanich V, et al
    Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  41. STROMDAHL M, Helgeson J, Kalaitzakis E
    Emergency readmission following acute upper gastrointestinal bleeding.
    Eur J Gastroenterol Hepatol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  42. JEE SR, Park MI, Lim SK, Kim SE, et al
    Clinical impact of second-look endoscopy after endoscopic submucosal dissection of gastric neoplasm: a multicenter prospective randomized-controlled trial.
    Eur J Gastroenterol Hepatol. 2016;28:546-52.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: